Stay updated on Her2 Therapy & Pembrolizumab in Neoadjuvant Clinical Trial
Sign up to get notified when there's something new on the Her2 Therapy & Pembrolizumab in Neoadjuvant Clinical Trial page.

Latest updates to the Her2 Therapy & Pembrolizumab in Neoadjuvant Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded a recruitment status note indicating enrollment is closed. Added/standardized navigation and help-content sections (How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment) and removed the older 'Intervention / Treatment' label to align with a site-wide formatting update.SummaryDifference0.4%

- Check17 days agoChange DetectedThe site now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates a recent software update to the platform and does not alter the study details or page content.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page's revision is updated from v3.5.3 to v3.5.4, indicating a new version of the page. This typically reflects minor edits or metadata adjustments in the page history.SummaryDifference0.0%

- Check60 days agoChange DetectedClinicalTrials.gov’s page footer revision label was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0. This appears to be a minor update with no visible changes to the study details.SummaryDifference0.0%

- Check96 days agoChange DetectedThe page’s revision tag was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Her2 Therapy & Pembrolizumab in Neoadjuvant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Her2 Therapy & Pembrolizumab in Neoadjuvant Clinical Trial page.